Al's Comment:

 This is an exciting project, looking at a new target to treat Glioblastomas.

This is the 81st brain tumor research grant awarded by the Musella Foundation! Thanks to the many donors who made it possible for us to fund these amazing projects!


Posted on: 11/25/2015

The Musella Foundation announced that it has awarded a $50,000 brain tumor research grant to Ninh Doan, MD, PhD, of the Medical College of Wisconsin.
 
 
 
Hewlett, NY, June 5, 2015 – The Musella Foundation For Brain Tumor Research & Information, Inc. (Musella Foundation), a non-profit organization dedicated to improving the lives of families dealing with brain cancer, announced that it has awarded a brain tumor research grant to Ninh Doan, MD, PhD, of the Medical College of Wisconsin, for his project “Development of Acid Ceramidase Inhibitors and Tumor Vaccine against Glioblastoma”.  This is preclinical work on a new target for brain tumor treatments. If successful, it will lead to a human clinical trial.
 
 
 
About the Musella Foundation
The Musella Foundation For Brain Tumor Research & Information, Inc is a 501(c)3 non- profit organization dedicated to speeding up the search for the cure of brain tumors, as well as helping families deal with the diagnosis of brain cancer, by funding innovative brain tumor research, education, advocacy, emotional and financial support for families that are dealing with brain tumors and organizing the brain tumor community to work together as an army to fight the disease. The “Clinical Trials and Noteworthy Treatments For Brain Tumors” website at http://virtualtrials.com, the “Brain Tumor Copayment Assistance Program”  website at http:// braintumorcopays.org, “The National Walk To End Brain Tumors” website at http://walktoendbraintumors.org and the “Grey Ribbon Crusade”  website at http://greyribboncrusade.org/ are all maintained by the Musella Foundation For Brain Tumor Research & Information.
 

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!